A phase I study of ALB 127158A for the treatment of obesity.

Trial Profile

A phase I study of ALB 127158A for the treatment of obesity.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2011

At a glance

  • Drugs ALB 127158A (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Sponsors AMRI
  • Most Recent Events

    • 05 Oct 2011 New trial record
    • 03 Oct 2011 Final results have been presented at the 29th Annual Scientific Meeting of the Obesity Society, according to an AMRI media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top